Resistive exercise blunts LPS-stimulated TNF-α and Il-1β

被引:26
作者
Phillips, M. D. [1 ]
Flynn, M. G. [2 ]
McFarlin, B. K. [3 ]
Stewart, L. K. [2 ,4 ]
Timmerman, K. L.
Ji, H. [5 ]
机构
[1] Texas Christian Univ, Dept Kinesiol, Ft Worth, TX 76123 USA
[2] Purdue Univ, Wastl Human Performance Lab, W Lafayette, IN 47907 USA
[3] Univ Houston, Houston, TX USA
[4] Louisiana State Univ, Dept Kinesiol, Baton Rouge, LA 70803 USA
[5] Second Mil Univ, Dept Basic & Med Sci, Shanghai, Peoples R China
关键词
interleukin-6 (IL-6); raloxifene; postmenopausal women; inflammatory cytokine;
D O I
10.1055/s-2007-965115
中图分类号
G8 [体育];
学科分类号
04 [教育学]; 0403 [体育学];
摘要
To examine the influence of acute resistive exercise and "hormone status" on cytokine profile, 35 postmenopausal women (72+/-6.2 yr) underwent a moderate-high-intensity resistive exercise bout or rested. There were 4 groups: no hormone replacement (NHR, n=9), hormone replacement (HRT, n = 12), selective estrogen receptor modulator (SER, n=7), or resting control (no hormone replacement, CON, n=7). NHR, HRT, and SER exercised (3 sets, 10 exercises @ 80% 1RM). Blood was collected pre-exercise (PR), postexercise (PO), and two hours (2H) postexercise (same times for CON). Blood was diluted 1 : 10 in culture medium and incubated (37 degrees C, 5% CO2, 24 h) with lipopolysaccharide (LPS, 25 mu g. ml(-1)). Serum and supernatant from LPS-stimulated blood were analyzed for IL-6, IL-1 beta and TNF-alpha using ELISA. Resistive exercise increased PO serum IL-6, and PO LPS-stimulated IL-6 and IL-1 beta in the exercise groups (HRT, NHR, SER collapsed; EX, n=28). LPS-stimulated IL-1 beta remained elevated at 2H in EX and was significantly higher than PR in CON at 2H. Expressed per monocyte, EX had significantly lower IL-1 beta and TNF-alpha LPS-stimulated production at PO and 2H compared to CON, indicating an exercise-induced blunting of an apparent diurnal response on cytokine production. In postmenopausal women, acute resistive exercise increased circulating IL-6, but reversed an apparent diurnal increase in LPS-stimulated IL-1 beta and TNF-alpha production with no influence of hormone replacement or raloxifene.
引用
收藏
页码:102 / 109
页数:8
相关论文
共 51 条
[1]
Effects of the natural and artificial menstrual cycle on the production of osteoprotegerin and the bone resorptive cytokines IL-1β and IL-6 [J].
Abrahamsen, B ;
Stilgren, LS ;
Rettmer, E ;
Bonnevie-Nielsen, V ;
Beck-Nielsen, H .
CALCIFIED TISSUE INTERNATIONAL, 2003, 72 (01) :18-23
[2]
Cytokine changes in postmenopausal women treated with estrogens: a placebo-controlled study [J].
Berg, G ;
Ekerfelt, C ;
Hammar, M ;
Lindgren, R ;
Matthiesen, L ;
Ernerudh, J .
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2002, 48 (02) :63-69
[3]
Bruunsgaard H, 1999, CLIN EXP IMMUNOL, V118, P235
[4]
Effect of concentric and eccentric muscle actions on muscle sympathetic nerve activity [J].
Carrasco, DI ;
Delp, MD ;
Ray, CA .
JOURNAL OF APPLIED PHYSIOLOGY, 1999, 86 (02) :558-563
[5]
Interleukin-6 (IL-6), IL-1, receptor activator of nuclear factor κB ligand (RANKL) and osteoprotegerin production by human osteoblastic cells:: comparison of the effects of 17-β oestradiol and raloxifene [J].
Cheung, J ;
Mak, YT ;
Papaioannou, S ;
Evans, BAJ ;
Fogelman, I ;
Hampson, G .
JOURNAL OF ENDOCRINOLOGY, 2003, 177 (03) :423-433
[6]
COHENSOLAL ME, 1995, J BONE MINER RES, V10, P307
[7]
Signal transduction in LPS-activated aged and young monocytes [J].
Delpedro, AD ;
Barjavel, MJ ;
Mamdouh, Z ;
Faure, S ;
Bakouche, O .
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1998, 18 (06) :429-437
[8]
Exercise and circadian rhythm-induced variations in plasma cortisol differentially regulate interleukin-1 beta (IL-1 beta), IL-6, and tumor necrosis factor-alpha (TNF alpha) production in humans: High sensitivity of TNF alpha and resistance of IL-6 [J].
DeRijk, R ;
Michelson, D ;
Karp, B ;
Petrides, J ;
Galliven, E ;
Deuster, P ;
Paciotti, G ;
Gold, PW ;
Sternberg, EM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (07) :2182-2191
[9]
Defining the proinflammatory phenotype using high sensitive C-reactive protein levels as the biomarker [J].
Devaraj, S ;
O'Keefe, G ;
Jialal, I .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (08) :4549-4554
[10]
Drenth JPH, 1998, EUR J CLIN INVEST, V28, P866